The diagnostic utility of EEG in early-onset dementia: a systematic review of the literature with narrative analysis

Abstract

Early-onset dementia (EOD) is characterized by functionally impairing deterioration in memory, language, personality or visuospatial skills emerging under the age of 65. Cerebral functioning can be assessed by visual electroencephalography (EEG) interpretation. The aim of this systematic review is to evaluate the diagnostic utility of visual EEG in EOD focusing on Alzheimer's disease (AD), vascular dementia (VAD), dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD). Medline, Embase, Scopus, Web of Knowledge, and Google Scholar were systematically searched for studies where EEGs were included in the diagnostic evaluation of patients with dementia under the age of 65. Each paper was quality assessed and the results grouped according to dementia cause with a narrative summary. 4,157 papers were screened, 12 studies met the eligibility criteria with a total of 965 patients. An abnormal EEG was common to all causes of EOD. EEG abnormalities are more severe in early-onset AD patients. EEG severity grade is independent of disease duration. Slow wave activity is common to all dementias, but is most prominent in DLB. Frontal intermittent rhythmic delta activity could be considered as supportive for the diagnosis of DLB as can a Grand Total EEG score of over 9.5. EEG is usually normal in FTD. Focal changes can be seen in advanced VAD. Studies employed small patient groups, varying diagnostic criteria, and only a minority of patient diagnoses was pathologically confirmed. EEG may be useful as an adjunct in the diagnosis of DLB and AD. Further prospective well-powered studies are required to investigate diagnostic utility more robustly.

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020

“…The full potential of neurodynamic time-sensitive biomarkers using electroencephalography (EEG) [289] and magnetoencephalography (MEG) [290] for quantification of degenerative brain changes during various stages of AD has yet to be realized. Subtle but consistent deviations in the electromagnetic neuronal dynamics have been shown to precede explicit cognitive manifestations in AD [291] which could enable a future role of EEG/MEG biomarkers not only as a clinical diagnosis and treatment option, but also as a new mode for AD stage discovery.…”

Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer’s Disease Detected Using Quantitative Electroencephalography

“…The advantages for the use of EEG as a diagnostic tool include its minimally invasiveness, easy storing and transportation, low cost, and better temporal resolution in relation to neuroimaging techniques [15]. Estimating intracranial sources of evoked related potentials (ERPs) during a semantic-matching task, an increase of the ERP generator strength in the left medial temporal lobe was found in the mutation carriers with respect to the non-carriers [16].…”

Testing Mean Differences among Groups: Multivariate and Repeated Measures Analysis with Minimal Assumptions

“…The EEG has the additional advantages of being highly available, free of radiation hazards, and noninvasive. It also appears to have considerable diagnostic utility in early-onset dementia (Micanovic & Pal, 2014) via extraction of biomarkers (Vecchio et al, 2013).…”